Impedimed Ltd (OTCPK:IPDQF)
$ 0.0421 0 (0%) Market Cap: 72.33 Mil Enterprise Value: 57.27 Mil PE Ratio: 0 PB Ratio: 4.21 GF Score: 0/100

Q2 2024 ImpediMed Ltd Activities Report Call Transcript

Feb 01, 2024 / 12:00AM GMT
Release Date Price: $0.06 (-33.33%)
Operator

Thank you for standing by, and welcome to the ImpediMed Limited 4C conference call. (Operator Instructions)

I would now like to turn the conference over to Dr. Parmjot Bains, Interim CEO and Managing Director. Please go ahead.

Parmjot Bains
ImpediMed Ltd - Interim Chief Executive Officer, Managing Director, Executive Director

Thank you. Good morning, and welcome to the ImpediMed investor call for the second quarter of fiscal 2024. My name is Parmjot Bains. It's good to meet you all virtually. I've been recently appointed Interim CEO and Managing Director of ImpediMed. And with me today is McGregor Grant, who is the Interim CFO and Executive Chairman of the company.

I'm sure as much of you are aware, McGregor and I were appointed to our respective executive roles at ImpediMed at the end of November 2023. And I only commenced on January 8 this year, so this is still very early days for us.

What I would like to do on this call is, firstly, introduce myself and provide a bit of background on my experience in life sciences and in the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot